Indian Pharmacopoeia Commission has newly added 19 system suitability/Quantitative impurities for the use of stakeholder

 

Name of Newly Added Impurities

Lot No.

Qty

Rate Per Vial (Private)

Rate Per Vial (Government)

Norfloxacin Impurity A

IMP/08/19

20mg

10,000/-

5,000/-

(+) - Dihydroquinidine

IMP/09/19

20mg

5,000/-

2,500/-

Proguanil Hydrochloride Impurity C

IMP/11/19

20mg

25,000/-

12,500/-

Lamivudine Impurity A

IMP/12/19

20mg

25,000/-

12,500/-

Clotrimazole Impurity B

IMP/13/19

20mg

10,000/-

5,000/-

Hydroxychloroquine sulphate

IMP/14/19

20mg

5,000/-

2,500/-

Pyridoxine Impurity A

IMP/15/19

20mg

15,000/-

7,500/-

Valproic Acid Impurity C

IMP/16/19

20mg

15,000/-

7,500/-

Glimepiride Impurity C

IMP/17/19

20mg

25,000/-

12,500/-

Etodolac Impurity C

IMP/18/19

20mg

25,000/-

12,500/-

Fenofibrate Impurity A

IMP/12/17

20mg

10,000/-

5,000/-

Proguanil Hydrochloride Impurity D

IMP/21/19

20mg

25,000/-

12,500/-

Rifampicin N-oxide

IMP/24/19

20mg

10,000/-

5,000/-

Glimepiride Impurity D

IMP/23/19

20mg

25,000/-

12,500/-

Pyridoxine Impurity B

IMP/20/19

20mg

15,000/-

7,500/-

Ondenseteron Impurity D

IMP/19/19

20mg

25,000/-

12,500/-

Ibuprofen Impurity F

IMP/22/19

20mg

25,000/-

12,500/-

Ondenseteron Impurity C

IMP/10/19

20mg

25,000/-

12,500/-

Mepyramine Maleate Impurity C

IMP/14/18

20mg

10,000/-

5,000/-

News & Highlights


View All

IPC Products

ip nfi
 
Connect with IPC